Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Goodwill & Intangibles (2014 - 2026)

Vericel (VCEL) posted Goodwill & Intangibles of $5.3 million for Q2 2026, down 2.85% sequentially from $5.5 million in Q1 2026, and down 10.53% YoY from $5.9 million in Q2 2025.

Analysis

Vericel (VCEL) Goodwill & Intangibles (2014 - 2026) Analysis & Trends

Vericel has reported Goodwill & Intangibles for 8 years, with the latest figure at $5.3 million in Q2 2026.

  • Quarterly Goodwill & Intangibles fell 10.53% year-over-year to $5.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.3 million (down 10.53% YoY) and the FY2025 annual result came in at $5.6 million, down 10.0% from the prior year.
  • Goodwill & Intangibles eased to $5.3 million in Q2 2026 per VCEL's latest filing, from $5.5 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $7.5 million in Q4 2022 and troughed at $5.3 million in Q2 2026.
  • A 5-year average of $6.4 million and a median of $6.4 million in 2024 frame the typical range for Goodwill & Intangibles.
  • The sharpest annual moves came in 2023 and 2026: Goodwill & Intangibles dropped 8.33% in 2023, then slipped 10.53% in 2026.
  • Over 5 years, Goodwill & Intangibles stood at $7.5 million in 2022, then fell by 8.33% to $6.9 million in 2023, then dropped by 9.09% to $6.2 million in 2024, then declined by 10.0% to $5.6 million in 2025, then dropped by 5.55% to $5.3 million in 2026.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $5.3 million, $5.5 million, and $5.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.31 Mn
Mar 31, 2026 5.47 Mn
Dec 31, 2025 5.63 Mn
Sep 30, 2025 5.78 Mn
Jun 30, 2025 5.94 Mn
Mar 31, 2025 6.09 Mn
Dec 31, 2024 6.25 Mn
Sep 30, 2024 6.41 Mn
Jun 30, 2024 6.56 Mn
Mar 31, 2024 6.72 Mn
Dec 31, 2023 6.88 Mn
Sep 30, 2023 7.03 Mn
Jun 30, 2023 7.19 Mn
Mar 31, 2023 7.34 Mn
Dec 31, 2022 7.50 Mn
Sep 30, 2016 2.71 Mn
Jun 30, 2016 2.78 Mn
Mar 31, 2016 2.85 Mn
Dec 31, 2015 2.92 Mn
Sep 30, 2015 2.99 Mn